Johnson & Johnson (JNJ)

Retained Earnings

$168.36B

Quarterly · Period ending: · USD

JNJ logo

JNJ Retained Earnings

Latest reported$168.36B
JNJ Quarterly Retained Earnings ($3.50B → $168.36B)
High-resolution chart · PNG

JNJ retained earnings history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Johnson & Johnson Retained Earnings — Quarterly (USD)
Period endingRetained Earnings (USD)
168,358,000,000
171,665,000,000
169,161,000,000
168,978,000,000
167,281,000,000
165,371,000,000
162,635,000,000
155,791,000,000
155,179,000,000
155,360,000,000
153,378,000,000
153,843,000,000
152,536,000,000
129,381,000,000
124,558,000,000
128,345,000,000
127,917,000,000
126,216,000,000
124,380,000,000
123,060,000,000
121,092,000,000
120,154,000,000
116,508,000,000
113,890,000,000
114,831,000,000
113,898,000,000
112,901,000,000
110,659,000,000
109,242,000,000
109,809,000,000
106,650,000,000
106,216,000,000
107,617,000,000
106,123,000,000
104,339,000,000
101,793,000,000
114,805,000,000
113,208,000,000
111,643,000,000
110,551,000,000
108,860,000,000
106,738,000,000
104,990,000,000
103,879,000,000
102,748,000,000
101,352,000,000
98,656,000,000
97,245,000,000
96,560,000,000
93,745,000,000
91,387,000,000
89,493,000,000
87,703,000,000
89,449,000,000
87,242,000,000
85,992,000,000
84,880,000,000
83,530,000,000
83,103,000,000
81,251,000,000
82,634,000,000
80,836,000,000
79,515,000,000
77,773,000,000
77,272,000,000
75,252,000,000
73,184,000,000
70,306,000,000
69,471,000,000
67,408,000,000
65,398,000,000
63,379,000,000
61,878,000,000
59,960,000,000
57,811,000,000
55,280,000,000
54,197,000,000
52,819,000,000
50,850,000,000
49,290,000,000
48,210,000,000
46,530,000,000
44,713,000,000
42,310,000,000
40,422,000,000
38,853,000,000
37,300,000,000
35,223,000,000
35,022,000,000
33,627,000,000
32,153,000,000
30,503,000,000
29,500,000,000
28,200,000,000
27,852,000,000
26,571,000,000
25,804,000,000
24,813,000,000
24,059,000,000
23,066,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.